Butyrylated starch increases colonic butyrate concentration but has limited effects on immunity in healthy physically active individuals

Exercise Immunology Review

Volumn 19, Issue , 2013, Pages 102-119

  West, Nicholas P ^a,b   Christophersen, Claus T ^c   Pyne, David B ^a   Cripps, Allan W ^b   Conlon, Michael A ^c   Topping, David L ^c   Kang, Seungha ^d   McSweeney, Chris S ^d   Fricker, Peter A ^a   Aguirre, Daniel ^d   Clarke, Julie M ^c  

^a AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c CSIRO   (Australia)

^d Livestock Industries ^*  (Australia)

Author keywords

Butyrylated starch; Exercise; Faecal microbiota; Immunity; Short chain fatty acids

Indexed keywords

ACETIC ACID; AMMONIA; BUTYRIC ACID; BUTYRYLATED HIGH AMYLOSE MAIZE STARCH; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; LOW AMYLOSE MAIZE STARCH; LYSOZYME; PROPIONIC ACID; STARCH; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; CYTOKINE;

ADULT; ARTICLE; BACTEROIDES; COLON FLORA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; HUMAN EXPERIMENT; INGESTION; MALE; MUCOSAL IMMUNITY; NORMAL HUMAN; PARABACTEROIDES DISTASONIS; PARALLEL DESIGN; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVA LEVEL; BIOSYNTHESIS; CHEMISTRY; COLON; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG EFFECT; FECES; IMMUNOLOGY; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SALIVA;

ADULT; BUTYRATES; COLON; CYTOKINES; DIETARY FIBER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SALIVA; STARCH;

EID: 84884198743     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abell G, Christophersen CT, McOrist AL, and Clarke JM. Dietary resistant and butyrylated starches have different effects on the faecal bacterial flora of azoxymethane-treated rats. Br J Nutr 105: 1480-1485, 2011.
2. Bailon E, Cueto-Sola M, Utrilla P, Rodriguez-Cabezas ME, Garrido-Mesa N, Zarzuelo A, Xaus J, Galvez J, and Comalada M. Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology 215: 863-873, 2010.
3. Bajka BH, Clarke JM, Cobiac L, and Topping DL. Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats. Carcinogenesis 29: 2169-2174, 2008.
4. Bajka BH, Topping DL, Cobiac L, and Clarke JM. Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat. Br J Nutr 96: 276-282, 2006.
5. Cherbut C. Inulin and oligofructose in the dietary fibre concept. Br J Nutr 87 Suppl 2: S159-162, 2002.
6. Clarke JM, Bird AR, Topping DL, and Cobiac L. Excretion of starch and esterified short-chain fatty acids by ileostomy subjects after the ingestion of acylated starches. Am J Clin Nutr 86: 1146-1151, 2007.
7. Clarke JM, Topping DL, Christophersen CT, Bird AR, Lange K, Saunders I, and Cobiac L. Butyrate esterified to starch is released in the human gastrointestinal tract. Am J Clin Nutr 94: 1276-1283, 2011.
8. Cox AJ, Pyne DB, Saunders PU, Callister R, and Gleeson M. Cytokine responses to treadmill running in healthy and illness-prone athletes. Med Sci Sports Exerc 39: 1918-1926, 2007.
9. Cummings JH, Beatty ER, Kingman SM, Bingham SA, and Englyst HN. Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr 75: 733-747, 1996.
10. Denman SE, and McSweeney CS. Development of a real-time PCR assay for monitoring anaerobic fungal and cellulolytic bacterial populations within the rumen. FEMS Microbiol Ecol 58: 572-582, 2006.
11. Fricker PA, Pyne DB, Saunders PU, Cox AJ, Gleeson M, and Telford RD. Influence of training loads on patterns of illness in elite distance runners. Clin J Sport Med 15: 246-252, 2005.
12. Gleeson M, and Bishop NC. Special feature for the Olympics: effects of exercise on the immune system: modification of immune responses to exercise by carbohydrate, glutamine and anti-oxidant supplements. Immunol Cell Biol 78: 554-561, 2000.
13. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, and Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11: 607-615, 2011.
14. Gleeson M, McDonald WA, Pyne DB, Cripps AW, Francis JL, Fricker PA, and Clancy RL. Salivary IgA levels and infection risk in elite swimmers. Med Sci Sports Exerc 31: 67-73, 1999.
15. Hopkins WG, Marshall SW, Batterham AM, and Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc 41: 3-13, 2009.
16. Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Hunter JO, and Cole JA. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 310: 138-144, 2010.
17. Kang S, Denman SE, Morrison M, Yu Z, Dore J, Leclerc M, and McSweeney CS. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis 16: 2034-2042, 2010.
18. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J, Verdu EF, and Tlaskalova-Hogenova H. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 2010.
19. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J, Verdu EF, and Tlaskalova-Hogenova H. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163: 250-259, 2011.
20. Lee H, Martin D, Anson J, Grundy D, and Hahn A. Physiological characteristics of successful mountain bikers and professional road cyclists. J Sports Sci 20: 1001- 1008, 2002.
21. Liu C, Song Y, McTeague M, Vu AW, Wexler H, and Finegold SM. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- And species-specific primers. FEMS Microbiol Lett 222: 9-16, 2003.
22. Macdonald TT. Inside the microbial and immune labyrinth: Totally gutted. Nat Med 16: 1194-1195, 2010.
23. Mathur N, and Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm 2008: 109502, 2008.
24. Ng V, Koh D, Chan G, Ong HY, Chia SE, and Ong CN. Are salivary immunoglobulin A and lysozyme biomarkers of stress among nurses? J Occup Environ Med 41: 920-927, 1999.
25. Ng V, Koh D, Mok B, Lim LP, Yang Y, and Chia SE. Stressful life events of dental students and salivary immunoglobulin A. Int J Immunopathol Pharmacol 17: 49-56, 2004.
26. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, and Pettersson S. Host-gut microbiota metabolic interactions. Science 336: 1262-1267, 2012.
27. Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, van Hall G, Plomgaard P, and Febbraio MA. Muscle-derived interleukin-6: lipolytic, antiinflammatory and immune regulatory effects. Pflugers Arch 446: 9-16, 2003.
28. Phillips J, Muir JG, Birkett A, Lu ZX, Jones GP, O'Dea K, and Young GP. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. Am J Clin Nutr 62: 121-130, 1995.
29. Smith PM, and Garrett WS. The gut microbiota and mucosal T cells. Front Microbiol 2: 111, 2011.
30. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottiere HM, Dore J, Marteau P, Seksik P, and Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736, 2008.
31. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, and Dore J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189, 2009.
32. Tarini J, and Wolever TM. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35: 9-16, 2010.
33. Tazoe H, Otomo Y, Karaki S, Kato I, Fukami Y, Terasaki M, and Kuwahara A. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res 30: 149-156, 2009.
34. Thomas D, and Atwell W. Starches: Practical guides for the food industry (p. 94). Saint Paul, Minnesota: Eagan Press, 1999.
35. van Munster IP, Tangerman A, and Nagengast FM. Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci 39: 834-842, 1994.
36. Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, and Curi R. Shortchain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci (Lond) 117: 331-338, 2009.
37. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, and Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 22: 849-855, 2011.
38. Walker AR, Walker BF, and Segal I. Faecal pH value and its modification by dietary means in South African black and white schoolchildren. S Afr Med J 55: 495-498, 1979.
39. West NP, Pyne DB, Kyd JM, Renshaw GM, Fricker PA, and Cripps AW. The effect of exercise on innate mucosal immunity. Br J Sports Med 44: 227-231, 2010.
40. Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt KA, Hu Y, Irahara N, Ogino S, Leggett BA, and Young GP. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90: 578-586, 2009.
41. Yu Z, and Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 36: 808-812, 2004.